Priscilla L. Yang

5.9k total citations · 1 hit paper
48 papers, 4.6k citations indexed

About

Priscilla L. Yang is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Priscilla L. Yang has authored 48 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Public Health, Environmental and Occupational Health, 16 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Priscilla L. Yang's work include Mosquito-borne diseases and control (24 papers), HIV Research and Treatment (10 papers) and Viral Infections and Vectors (9 papers). Priscilla L. Yang is often cited by papers focused on Mosquito-borne diseases and control (24 papers), HIV Research and Treatment (10 papers) and Viral Infections and Vectors (9 papers). Priscilla L. Yang collaborates with scholars based in United States, Singapore and China. Priscilla L. Yang's co-authors include Nathanael S. Gray, Jianming Zhang, Alana Althage, Josan Chung, Francis V. Chisari, Aaron G. Schmidt, Stephen C. Harrison, Mélissanne de Wispelaere, Mary A. Rodgers and Justin Jang Hann Chu and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Priscilla L. Yang

48 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting cancer with small molecule kinase inhibitors

2008 2.0k citations Jianming Zhang, Priscilla L. Yang et al. Nature reviews. Cancer profile →

Peers

Priscilla L. Yang

PHEOH

ONCOL

EPIDE

Nicole Zitzmann United Kingdom

Antonello Pessi Italy

Karl Ziegelbauer Germany

Torsten Steinmetzer Germany

Curtis R. Chong United States

José A. Esté Spain

Doron C. Greenbaum United States

Michael Foley Australia

Paul A. Ramsland Australia

Paul R. Caron United States

Nicole Zitzmann United Kingdom

Priscilla L. Yang

2.9k ×1.3

584 ×0.6

PHEOH

1.0k ×1.1

258 ×0.3

ONCOL

1.5k ×2.1

EPIDE

Citations per year, relative to Priscilla L. Yang Priscilla L. Yang (= 1×) peers Nicole Zitzmann

Countries citing papers authored by Priscilla L. Yang

Since Specialization

Citations

This map shows the geographic impact of Priscilla L. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla L. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla L. Yang more than expected).

Fields of papers citing papers by Priscilla L. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla L. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla L. Yang. The network helps show where Priscilla L. Yang may publish in the future.

Co-authorship network of co-authors of Priscilla L. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Priscilla L. Yang. A scholar is included among the top collaborators of Priscilla L. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscilla L. Yang. Priscilla L. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Han‐Yuan, Zhengnian Li, Zhixiang He, et al.. (2024). Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism. Nature Communications. 15(1). 5179–5179. 11 indexed citations

Słabicki, Mikołaj, J. J. Patten, Charles Zou, et al.. (2022). Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy. Journal of Medical Virology. 95(1). e28157–e28157. 18 indexed citations

Villareal, Valerie A., Chih‐Yun Hsia, Mary A. Rodgers, et al.. (2020). Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase. Journal of Biological Chemistry. 295(35). 12426–12436. 13 indexed citations

Wispelaere, Mélissanne de, Guangyan Du, Katherine A. Donovan, et al.. (2019). Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations. Nature Communications. 10(1). 3468–3468. 156 indexed citations

Pitts, Jared, Chih‐Yun Hsia, Wenlong Lian, et al.. (2019). Identification of small molecule inhibitors targeting the Zika virus envelope protein. Antiviral Research. 164. 147–153. 18 indexed citations

Wispelaere, Mélissanne de, Margot Carocci, Dominique J. Burri, et al.. (2019). A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation. Journal of Biological Chemistry. 295(6). 1694–1703. 2 indexed citations

Li, Pi‐Chun, et al.. (2017). Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus. Antiviral Research. 147. 124–130. 26 indexed citations

Cuevas, Christian, Margot Carocci, Sarah H. Stubbs, et al.. (2016). Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor. Journal of Virology. 90(9). 4494–4510. 26 indexed citations

Carocci, Margot & Priscilla L. Yang. (2016). Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses. Antiviral Research. 128. 57–62. 23 indexed citations

10.

Villareal, Valerie A., et al.. (2015). Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses. Antiviral Research. 124. 110–121. 60 indexed citations

11.

Wispelaere, Mélissanne de, Amy Lacroix, & Priscilla L. Yang. (2013). The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase. Journal of Virology. 87(13). 7367–7381. 105 indexed citations

12.

Zhang, Zijuan, Nicholas Kwiatkowski, Hong Zeng, et al.. (2012). Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopy. Molecular BioSystems. 8(10). 2523–2526. 21 indexed citations

13.

Rodgers, Mary A., Valerie A. Villareal, Esperance Schaefer, et al.. (2012). Lipid Metabolite Profiling Identifies Desmosterol Metabolism as a New Antiviral Target for Hepatitis C Virus. Journal of the American Chemical Society. 134(16). 6896–6899. 36 indexed citations

14.

Yang, Priscilla L., Min Gao, Kai Lin, Qingsong Liu, & Valerie A. Villareal. (2011). Anti-HCV drugs in the pipeline. Current Opinion in Virology. 1(6). 607–616. 56 indexed citations

15.

Schmidt, Aaron G., Priscilla L. Yang, & Stephen C. Harrison. (2010). Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate. PLoS Pathogens. 6(4). e1000851–e1000851. 111 indexed citations

16.

Sessions, October M., Nicholas J. Barrows, Jayme A. Souza‐Neto, et al.. (2009). Discovery of insect and human dengue virus host factors. Nature. 458(7241). 1047–1050. 305 indexed citations

17.

Chu, Justin Jang Hann & Priscilla L. Yang. (2008). Pharmacological C-Abl Kinase Inhibitors as Potential Anti-Viral Molecules for Dengue Virus. International Journal of Infectious Diseases. 12. e297–e297. 1 indexed citations

18.

Zhang, Jianming, Priscilla L. Yang, & Nathanael S. Gray. (2008). Targeting cancer with small molecule kinase inhibitors. Nature reviews. Cancer. 9(1). 28–39. 2032 indexed citations breakdown →

19.

Gildersleeve, Jeffrey C., Jeff Janes, Helle D. Ulrich, et al.. (2002). Development of a genetic selection for catalytic antibodies. Bioorganic & Medicinal Chemistry Letters. 12(12). 1691–1694. 1 indexed citations

20.

Yang, Priscilla L. & Peter G. Schultz. (1999). Mutational analysis of the affinity maturation of antibody 48G7. Journal of Molecular Biology. 294(5). 1191–1201. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact